Comment

. 2019 Sep:66:265-266.

doi: 10.1016/j.parkreldis.2019.08.010. Epub 2019 Aug 12.

The gut microbiota: A novel therapeutic target in Parkinson's disease?

Michal Lubomski¹, Ryan L Davis², Carolyn M Sue³

Affiliations

¹ Department of Neurology, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia; Department of Neurogenetics, Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia; The University of Notre Dame Australia, School of Medicine, Sydney, NSW, Australia. Electronic address: mlub6241@uni.sydney.edu.au.
² Department of Neurogenetics, Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia.
³ Department of Neurology, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia; Department of Neurogenetics, Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia.

PMID: 31445904
DOI: 10.1016/j.parkreldis.2019.08.010

Comment

The gut microbiota: A novel therapeutic target in Parkinson's disease?

Michal Lubomski et al. Parkinsonism Relat Disord. 2019 Sep.

. 2019 Sep:66:265-266.

doi: 10.1016/j.parkreldis.2019.08.010. Epub 2019 Aug 12.

Authors

Michal Lubomski¹, Ryan L Davis², Carolyn M Sue³

Affiliations

¹ Department of Neurology, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia; Department of Neurogenetics, Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia; The University of Notre Dame Australia, School of Medicine, Sydney, NSW, Australia. Electronic address: mlub6241@uni.sydney.edu.au.
² Department of Neurogenetics, Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia.
³ Department of Neurology, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia; Department of Neurogenetics, Kolling Institute, Faculty of Medicine and Health, University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia.

PMID: 31445904
DOI: 10.1016/j.parkreldis.2019.08.010

No abstract available

Keywords: Gastrointestinal microbiota; Levodopa; Metabolism; Parkinson's disease; Therapy.

PubMed Disclaimer

Comment on

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.
van Kessel SP, Frye AK, El-Gendy AO, Castejon M, Keshavarzian A, van Dijk G, El Aidy S. van Kessel SP, et al. Nat Commun. 2019 Jan 18;10(1):310. doi: 10.1038/s41467-019-08294-y. Nat Commun. 2019. PMID: 30659181 Free PMC article.
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism.
Maini Rekdal V, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP. Maini Rekdal V, et al. Science. 2019 Jun 14;364(6445):eaau6323. doi: 10.1126/science.aau6323. Science. 2019. PMID: 31196984 Free PMC article.

Cited by

The impact of device-assisted therapies on the gut microbiome in Parkinson's disease.
Lubomski M, Xu X, Holmes AJ, Yang JYH, Sue CM, Davis RL. Lubomski M, et al. J Neurol. 2022 Feb;269(2):780-795. doi: 10.1007/s00415-021-10657-9. Epub 2021 Jun 15. J Neurol. 2022. PMID: 34128115
Nutritional Intake and Gut Microbiome Composition Predict Parkinson's Disease.
Lubomski M, Xu X, Holmes AJ, Muller S, Yang JYH, Davis RL, Sue CM. Lubomski M, et al. Front Aging Neurosci. 2022 May 11;14:881872. doi: 10.3389/fnagi.2022.881872. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35645785 Free PMC article.
Enteric glia in homeostasis and disease: From fundamental biology to human pathology.
Rosenberg HJ, Rao M. Rosenberg HJ, et al. iScience. 2021 Jul 15;24(8):102863. doi: 10.1016/j.isci.2021.102863. eCollection 2021 Aug 20. iScience. 2021. PMID: 34401661 Free PMC article. Review.
Lower GDNF Serum Level Is a Possible Risk Factor for Constipation in Patients With Parkinson Disease: A Case-Control Study.
Chen G, Du Y, Li X, Kambey PA, Wang L, Xia Y, Tang C, Shi M, Zai-Li L, Zai-E X, Xiao-Ling Q, Dian-Shuai G. Chen G, et al. Front Neurol. 2022 Jan 13;12:777591. doi: 10.3389/fneur.2021.777591. eCollection 2021. Front Neurol. 2022. PMID: 35095724 Free PMC article.
Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.
Liebert A, Bicknell B, Laakso EL, Heller G, Jalilitabaei P, Tilley S, Mitrofanis J, Kiat H. Liebert A, et al. BMC Neurol. 2021 Jul 2;21(1):256. doi: 10.1186/s12883-021-02248-y. BMC Neurol. 2021. PMID: 34215216 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The gut microbiota: A novel therapeutic target in Parkinson's disease?

Affiliations

The gut microbiota: A novel therapeutic target in Parkinson's disease?

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical